StarTric

StarTric is dedicated to advancing the treatment of tricuspid regurgitation through innovative medical device technology. Focused on developing a minimally invasive repair device, StarTric aims to replicate the highly effective edge-to-edge Clover repair technique, offering a safer and more accessible solution for a broad patient population.

With its headquarters in Milan, IT, StarTric is committed to pioneering next-generation technologies that are safe, effective, easy to use, and personalized. The company's device is designed specifically for the tricuspid valve, building on the legacy of established surgical techniques to improve patient outcomes and quality of life.

StarTric's ongoing product development promises to transform the landscape of tricuspid regurgitation treatment. We invite the management of StarTric to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.